Biofrontera uses the long summer months to introduce daylight photodynamic therapy (PDT) with Ameluz® in the EU
17 sept. 2018 05h17 HE
|
Biofrontera AG
Leverkusen, Germany, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today announced an update on...